Breast cancer screening could be made more accurate with the help of an oral pill that “lights up” cancerous tumors. This is according to new research recently presented at the 251st National Meeting & Exposition of the American Chemical Society in San Diego, CA.
After skin cancer, breast cancer is the most common cancer in American women. This year, it is expected that more than 246,000 women will be diagnosed with an invasive form of the disease.
While the number of women affected by breast cancer remains high, rates of the disease have been falling since 1989, which is partly attributed to early detection as a result of increased breast cancer screening.
